Telmitan M 40mg/50mg Tablet ER

Name: Telmitan M 40mg/50mg Tablet ER
Brand: Accilex Diacardo
Price: 90 INR

Prescription Required

Marketer

Accilex Diacardo

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (50mg)

Overview Telmitan M 40mg/50mg Tablet ER

Telmitan M 40mg/50mg Extended-Release tablets manage hypertension, reducing the risk of cardiovascular events like heart attacks and strokes. Early intervention significantly improves survival rates following a heart attack. Consistent blood levels are achieved by taking this medication with food at the same time daily, as directed by your physician. Continued use, even with asymptomatic hypertension, is crucial; premature discontinuation can worsen the condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, further contribute to blood pressure control. Strict adherence to your doctor's instructions is essential. Potential side effects include headache, weakness, dizziness, hypotension (sometimes with fainting), shortness of breath, nausea, vomiting, stomach pain, fatigue, and elevated potassium levels. Potassium-rich foods and supplements should be avoided. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood glucose, kidney function, and electrolyte levels may be necessary. Prior to commencing treatment, inform your doctor of any kidney or liver issues, pregnancy, or breastfeeding. Always disclose all medications, especially those for hypertension or cardiac conditions.

Uses of Telmitan M 40mg/50mg Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telmitan M 40mg/50mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmitan M 40mg/50mg Extended-Release tablet whole; do not fragment or chew it. Administer this medicine with a meal.

Common Side effects of Telmitan M 40mg/50mg Tablet ER:

Headache
Weakness
Dizziness
Cold extremities
Slow heart rate
Increased potassium level in blood
Decreased blood pressure
Orthostatic hypotension (sudden lowering of blood pressure on standing)
Breathlessness
Vomiting
Abdominal pain

How to use Telmitan M 40mg/50mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmitan M 40mg/50mg Extended-Release tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with a meal.

How Telmitan M 40mg/50mg Tablet ER works:

Telmisartan and Metoprolol Succinate, combined as Telmitan M 40mg/50mg Extended-Release tablets, offer a dual approach to hypertension management.

SAFETY ADVICE

AlcoholUNSAFE

Consuming alcohol alongside Telmitan M 40mg/50mg Extended-Release Tablets is inadvisable.

PregnancyCONSULT YOUR DOCTOR

Extended-release Telmitan M 40mg/50mg tablets pose a confirmed risk to the fetus and should not be taken during pregnancy. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingSAFE IF PRESCRIBED

Extended-release Telmitan M 40mg/50mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.

DrivingUNSAFE

Extended-release Telmitan M 40mg/50mg tablets can cause drowsiness, blurred vision, and dizziness. Driving is prohibited if these effects are experienced.

KidneySAFE IF PRESCRIBED

Telmitan M 40mg/50mg extended-release tablets are considered safe for individuals with impaired renal function. No modification of the Telmitan M 40mg/50mg extended-release tablet dosage is necessary.

LiverCAUTION

Patients with hepatic impairment should use Telmitan M 40mg/50mg Extended-Release tablets cautiously. Dosage modifications may be necessary; physician consultation is advised.

What if you forget to take Telmitan M 40mg/50mg Tablet ER :

Should you forget a Telmitan M 40mg/50mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Telmitan M 40mg/50mg Tablet ER

Label	Value
Addictive	None.
Treatment Category	HEART

FAQs on Telmitan M 40mg/50mg Tablet ER

Indeed, Telmitan M 40mg/50mg Extended-Release Succinate tablets can cause dizziness. This side effect is often experienced upon standing after a period of lying down or sitting. To mitigate dizziness or fainting, stand gradually from a seated or recumbent position.

Improving your lifestyle alongside Telmitan M 40mg/50mg Tablet ER Succinate use significantly enhances overall well-being. Quitting smoking is crucial, as it elevates the risk of stroke and heart attack. Weight management is essential for those who are overweight or obese. A balanced diet rich in fruits and vegetables is recommended. Consistent physical activity strengthens the heart and lowers the likelihood of cardiac events.

Continue taking your prescribed Telmitan M 40mg/50mg Extended-Release tablets as directed, even if you're feeling healthy. Abrupt cessation of Telmitan M 40mg/50mg Extended-Release tablets can result in severe adverse events, including myocardial infarction and cerebrovascular accident.

Store this medication in its original, tightly sealed container, following the storage instructions provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and other individuals.

MRP 110

18% off

Inclusive of all taxes

Quantity:

of 10 Tablet ER

Telmitan M 40mg/50mg Tabl...